Archer-Daniels (ADM) was downgraded to market perform at BMO Capital. $48 price target. The company will likely struggle to achieve long-term earnings goals, BMO said.
American International (AIG) was upgraded to outperform from neutral at Credit Suisse. $75 price target. It appears the P&C business can turn around, Credit Suisse said.
Allstate (ALL) was downgraded to neutral from outperform at Credit Suisse. The valuation is less attractive, based on an $80 price target.
Cognizant (CTSH) was upgraded to outperform from neutral at Wedbush. $70 price target. The company is leveraged to higher IT spending, as suggested by a recent survey, Wedbush said.
Hershey (HSY) was upgraded to outperform from neutral at Credit Suisse. $117 price target. There's confidence that management can turn the business around in the coming quarters, Credit Suisse said.
Healthways (HWAY) was upgraded to buy from hold at Jefferies. The valuation is more attractive, based on a $29 price target.
Roper (ROP) was upgraded to outperform from perform at Oppenheimer. $225 price target. Earnings estimates also increased, given the company's recent acquisition, Oppenheimer said.
Teleflex (TFX) was upgraded to buy at Jefferies. $180 price target. The company's recent acquisition can boost margins and earnings, Jefferies said.